An Illinois state appeals panel has agreed that generic drug makers can’t face lawsuits claiming Zantac causes cancer. Plaintiff Angela Valadez said she developed colorectal cancer, allegedly as a result of treating heartburn from 1995 to 2014 by taking Zantac and ranitidine, its generic equivalent. She sued Zantac-maker GlaxoSmithKline and Boehringer Engelheim, which made and sold the active ingredient ranitidine,…

Etzler Lawhead Legal Group, PCJuly 21, 2025